Monitoring of COVID-19-Associated Coagulopathy and Anticoagulation with Thromboelastometry
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Monitoring of COVID-19-Associated Coagulopathy and Anticoagulation with Thromboelastometry ; volume:48 ; number:3 ; year:2021 ; pages:168-172 ; extent:5
Transfusion medicine and hemotherapy ; 48, Heft 3 (2021), 168-172 (gesamt 5)
- Creator
-
Katz, Daniel
Maher, Patrick
Getrajdman, Chloe
Hamburger, Joshua
Zhao, Shan
Madek, Jonathan
Bhatt, Himani
Levin, Matthew
Görlinger, Klaus
- DOI
-
10.1159/000514486
- URN
-
urn:nbn:de:101:1-2021061000133639412229
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Katz, Daniel
- Maher, Patrick
- Getrajdman, Chloe
- Hamburger, Joshua
- Zhao, Shan
- Madek, Jonathan
- Bhatt, Himani
- Levin, Matthew
- Görlinger, Klaus
Other Objects (12)
COVID-19-associated coagulopathy
COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation
Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy
COVID-19-Associated Coagulopathy in the Peripartum Setting: A Case Report
COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU
Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis
Coagulopathy is associated with multiple organ damage and prognosis of COVID-19
The unique characteristics of COVID-19 coagulopathy
COVID-19 Coagulopathy: From Pathogenesis to Treatment
Immune-Mediated Coagulopathy in COVID-19 Infection
Variability in Institutional Guidance for COVID-19-Associated Coagulopathy in the United States
Coagulopathy in COVID-19: Connecting the Dots Together
COVID-19-associated coagulopathy
COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation
Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy
COVID-19-Associated Coagulopathy in the Peripartum Setting: A Case Report
COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU
Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis
Coagulopathy is associated with multiple organ damage and prognosis of COVID-19
The unique characteristics of COVID-19 coagulopathy
COVID-19 Coagulopathy: From Pathogenesis to Treatment
Immune-Mediated Coagulopathy in COVID-19 Infection
Variability in Institutional Guidance for COVID-19-Associated Coagulopathy in the United States
Coagulopathy in COVID-19: Connecting the Dots Together
COVID-19-associated coagulopathy
COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation
Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy
COVID-19-Associated Coagulopathy in the Peripartum Setting: A Case Report
COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU
Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis
Coagulopathy is associated with multiple organ damage and prognosis of COVID-19
The unique characteristics of COVID-19 coagulopathy
COVID-19 Coagulopathy: From Pathogenesis to Treatment
Immune-Mediated Coagulopathy in COVID-19 Infection
Variability in Institutional Guidance for COVID-19-Associated Coagulopathy in the United States